Article
Post-surgery level of circulating DNA in stage III colon cancer patients: impact on the reliability of minimal residual disease detection
2025-04-06
Abstract excerpt
<h4>Purpose</h4> Minimal residual disease (MRD) assessment guided by circulating DNA (cir-nDNA) testing is strongly prognostic in operable colon cancer patients. However, further clinical research to result in fully changing the clinical management of colon cancer about the use of adjuvant therapy. <h4>Experimental Design</h4> In order to improve the analytical signal sensitivity of MRD detection we investigated t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bdcb8970-ad11-52eb-84e5-2784e73d4b68
- DOI
- 10.1101/2025.04.04.25324955
